A successful debut for IMPACT in Washington, D.C.

IMPACT made its official debut this summer at the 33rd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Washington, D.C.

For the first time, clinicians, researchers and industry partners had the chance to see our new platelet function analyser in action. From hands-on demonstrations to insightful conversations, the interest and feedback around IMPACT exceeded expectations.

Designed to support fast, reliable results in both laboratory and point-of-care settings, IMPACT is built on decades of haemostasis expertise through Hart Biologicals and shaped by real-world clinical needs.

The event marked an exciting milestone in the journey of the IMPACT product line. The response from the global haemostasis community confirmed the need for a next-generation solution in platelet function testing.

Our team also joined an event hosted by DiaPharma, our U.S. distributor for IMPACT. It was a great way to celebrate the beginning of a strong partnership and the rollout ahead.

IMPACT is due for release in 2026 and will shortly be available for Research Use Only (RUO).

Want to learn more or connect with our team?
Visit our Contact page for any questions, collaborations or updates.

Thank you to everyone who joined us at ISTH 2025. Your support and feedback mean a great deal as we move forward.